Viewpoint: the role of the rheumatologist in managing immune-related adverse events caused by cancer immunotherapy

Rheumatologists should be central figures in this evolving field. INTRODUCTION Immune checkpoint inhibitors are a type of immunotherapy used to treat cancer. There are six drugs in this group, and they are used in more than 10 cancer types. This type of treatment for cancer is now very common and there are hundreds of thousands […]

Read More…

No additional risk of breast cancer recurrence with TNF inhibitors

Breast cancer survivors receiving TNF inhibitors for rheumatoid arthritis are not at an increased risk of their cancer recurring compared to those receiving other medicines. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. […]

Read More…